At 21.0% CAGR, e-prescriptions market size valued at US$4,017.79 million…

At 21.0% CAGR, e-prescriptions market size valued at US$4,017.79 million…

Facebook
Twitter
LinkedIn

Pune, India, Nov. 01, 2022 (GLOBE NEWSWIRE) — The global Electronic Prescriptions Market The size is expected to reach $4,017.79 million by the end of 2026, driven by the integration of e-prescription software with electronic medical record (EHR) solutions. E-prescribing or electronic prescribing is a new technological infrastructure that helps medical professionals to write prescriptions and send them directly to the pharmacy.

Key Industry Development:

December 2019 – An independent company specializing in integrated prescription and cost transparency solutions called RxRevu has entered into a collaboration agreement with Cerner Corporation, which provides patient prescription pricing solutions for EHR.

Request a PDF sample brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/e-prescribing-market-102698

Report scope:

report coverage details
forecast period 2019 to 2026
Forecast period 2019 to 2026 CAGR 21.0%
Value prognosis 2026 $4,017.79 million
base year 2018
Market size in 2018 $863.64 million
Historical data for 2015 to 2017
number of pages 140

Driver and restraint systems:

Cost efficiency features to increase the market

The ePrescription software program enables doctors to submit a prescription to pharmacies and clinics without losing the patient’s medical history. This, coupled with the associated benefits, such as quality medical care and improved patient safety, are the key factors fueling the growth of the ePrescriptions market. Also, they are convenient for both the doctor and the patient. They are less expensive compared to the traditional prescription methods. This would increase the growth of the market over the forecast period.

On the other hand, implementing a new e-prescription setup is expensive and also requires high maintenance costs. This could hamper the market growth in the years to come. Nevertheless, the introduction of these therapeutic solutions in emerging markets is expected to generate new…

[ad_2]

Source story

More to explorer